Healthier Capital, launched by former ex-CEO of One Medical Amir Dan Rubin, has secured $220 million for its first healthcare technology fund, exceeding its fundraising target.
According to the firm, investors in Fund I include endowments, universities, family offices, healthcare systems and other institutional backers. The fund closed well above its original $150 million goal, even as many limited partners have pulled back from venture investing.
The raise comes amid a broader slowdown in the venture market. Fundraising across the global venture capital industry fell to an eight-year low in 2025, declining nearly 40% compared with 2024, as per the Venture Capital Journal.
Rubin said Healthier Capital’s ability to attract capital is driven by its leadership team’s extensive experience across the healthcare landscape. The firm is staffed by operators who have managed hospitals and provider organizations, held senior leadership roles at companies such as CVS Health, led large-scale healthcare mergers and acquisitions, and served as researchers and educators at top institutions.
Rubin led primary care company One Medical as CEO for six years. The company completed its initial public offering in 2020 before being acquired by Amazon for $3.9 billion in 2023. His career also includes senior leadership roles across major healthcare organizations, including UnitedHealth Group’s Optum division.
Healthier Capital partner Gregor Kevrekian previously served as head of corporate development at CVS Health, where he oversaw major acquisitions such as Oak Street Health and Signify Health.
Eric Epstein, a partner at Healthier Capital, previously held a partnership role at Santé Ventures. His background also includes work in healthcare consulting at McKinsey & Company in Silicon Valley, where he focused on operational improvement and strategic initiatives across the healthcare sector.
Another partner, Aman Mahajan, brings a blend of clinical and entrepreneurial experience. He is a physician-scientist and clinical leader who has founded and invented multiple health technology and digital health platforms.
Rubin said that limited partners, founders and co-investors recognize the firm’s depth of experience, explaining that the team has taken companies public, completed strategic sales, acquired businesses and invested across the sector for decades.
Rubin said that the firm aims to make healthcare work better for everyone, which is why it spends significant time engaging with health systems, clinicians and life sciences organizations. He explained that these organizations increasingly view the firm as a partner in their innovation efforts, a role the team actively embraces.
He added that while much of the firm’s focus is on startups and how modern AI and emerging technologies can be applied in healthcare, it also has a deep understanding of the existing healthcare ecosystem.
Healthier Capital has completed nine investments so far, concentrating largely on early-stage startups developing AI-enabled diagnostic tools, care delivery models and clinical workflow technologies. The firm has already recorded its first portfolio exit: Ezra, a company offering full-body imaging services, was acquired by Function Health in 2025.
Rubin said Healthier Capital is centered on improving health outcomes broadly by working alongside technology-driven innovators.
Healthier Capital Debuts $220M Healthcare Venture Fund
Healthier Capital has officially entered the spotlight with the debut of a $220 million healthcare-focused venture fund, marking a major milestone for Healthier Capital in the global investment landscape. The new fund highlights how Healthier Capital is doubling down on its mission to back innovative healthcare companies that are transforming patient care, digital health, and medical technologies.
With this launch, Healthier Capital aims to support early- and growth-stage startups that are building scalable solutions across healthcare services, health IT, and life sciences. Industry observers note that Healthier Capital is positioning itself as a long-term partner for founders by combining capital with strategic expertise and deep sector knowledge.
